In the past week, CDXS stock has gone up by 19.75%, with a monthly gain of 22.44% and a quarterly surge of 26.49%. The volatility ratio for the week is 7.98%, and the volatility levels for the last 30 days are 5.99% for Codexis Inc The simple moving average for the past 20 days is 17.18% for CDXS’s stock, with a 20.00% simple moving average for the past 200 days.
Is It Worth Investing in Codexis Inc (NASDAQ: CDXS) Right Now?
Moreover, the 36-month beta value for CDXS is 2.05. Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CDXS is 78.91M and currently, short sellers hold a 2.54% of that float. On November 06, 2024, CDXS’s average trading volume was 582.08K shares.
CDXS) stock’s latest price update
The stock price of Codexis Inc (NASDAQ: CDXS) has jumped by 9.46 compared to previous close of 3.49. Despite this, the company has seen a gain of 19.75% in its stock price over the last five trading days. globenewswire.com reported 2024-11-04 that REDWOOD CITY, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that management will participate in four upcoming investor conferences.
Analysts’ Opinion of CDXS
Jefferies, on the other hand, stated in their research note that they expect to see CDXS reach a price target of $5. The rating they have provided for CDXS stocks is “Buy” according to the report published on June 03rd, 2024.
Cantor Fitzgerald gave a rating of “Overweight” to CDXS, setting the target price at $11 in the report published on May 30th of the current year.
CDXS Trading at 24.17% from the 50-Day Moving Average
After a stumble in the market that brought CDXS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.20% of loss for the given period.
Volatility was left at 5.99%, however, over the last 30 days, the volatility rate increased by 7.98%, as shares surge +24.43% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +20.89% upper at present.
During the last 5 trading sessions, CDXS rose by +19.75%, which changed the moving average for the period of 200-days by +35.94% in comparison to the 20-day moving average, which settled at $3.26. In addition, Codexis Inc saw 25.25% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CDXS starting from Opaleye Management Inc., who purchase 25,000 shares at the price of $2.91 back on Oct 25 ’24. After this action, Opaleye Management Inc. now owns 8,545,000 shares of Codexis Inc, valued at $72,720 using the latest closing price.
Opaleye Management Inc., the 10% Owner of Codexis Inc, purchase 80,000 shares at $2.94 during a trade that took place back on Sep 24 ’24, which means that Opaleye Management Inc. is holding 8,515,000 shares at $234,856 based on the most recent closing price.
Stock Fundamentals for CDXS
Current profitability levels for the company are sitting at:
- -0.79 for the present operating margin
- 0.7 for the gross margin
The net margin for Codexis Inc stands at -0.96. The total capital return value is set at -0.45. Equity return is now at value -75.31, with -41.03 for asset returns.
Based on Codexis Inc (CDXS), the company’s capital structure generated 0.31 points at debt to capital in total, while cash flow to debt ratio is standing at -1.34. The debt to equity ratio resting at 0.45. The interest coverage ratio of the stock is -8.59.
Currently, EBITDA for the company is -44.88 million with net debt to EBITDA at 0.21. When we switch over and look at the enterprise to sales, we see a ratio of 4.69. The receivables turnover for the company is 3.9for trailing twelve months and the total asset turnover is 0.43. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.21.
Conclusion
To wrap up, the performance of Codexis Inc (CDXS) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
